Managed Account Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | $6.43M | Buy |
644,079
+13,129
| +2% | +$131K | 0.01% | 1299 |
|
|
2015
Q1 | $8.03M | Buy |
630,950
+57,132
| +10% | +$727K | 0.01% | 1188 |
|
|
2014
Q4 | $8.12M | Buy |
573,818
+666
| +0.1% | +$9.42K | 0.01% | 1154 |
|
|
2014
Q3 | $7.88M | Buy |
573,152
+135,747
| +31% | +$1.87M | 0.01% | 1140 |
|
|
2014
Q2 | $6.73M | Buy |
437,405
+25,225
| +6% | +$388K | 0.01% | 1218 |
|
|
2014
Q1 | $7.02M | Buy |
412,180
+184,365
| +81% | +$3.14M | 0.01% | 1148 |
|
|
2013
Q4 | $2.95M | Buy |
227,815
+217,099
| +2,026% | +$2.81M | ﹤0.01% | 1554 |
|
|
2013
Q3 | $108K | Buy |
10,716
+5,274
| +97% | +$53.2K | ﹤0.01% | 2216 |
|
|
2013
Q2 | $41K | Buy |
+5,442
| New | +$41K | ﹤0.01% | 2300 |
|